Is Now the Time for the Fourth BNT162b2 Dose for Residents of Long-term Care Facilities?
J Gerontol A Biol Sci Med Sci
.
2022 Jul 5;77(7):1380-1381.
doi: 10.1093/gerona/glac044.
Authors
Galia Rahav
1
,
Nimrod Maimon
2
,
Rebeca Halperin
1
,
Ital Nemet
3
,
Yitshak Kreiss
4
,
Arnon Afek
4
,
Michal Mandelboim
3
Affiliations
1
Sheba Medical Center, Infectious Diseases Unit, Tel-Hashomer, Israel.
2
Soroka University Medical Center, Internal Medicine Beer-Sheva, Israel.
3
Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel.
4
Sheba Medical Center, General Management, Tel-Hashomer, Israel.
PMID:
35192714
DOI:
10.1093/gerona/glac044
No abstract available
MeSH terms
Aged
BNT162 Vaccine*
Homes for the Aged
Humans
Long-Term Care*
Nursing Homes
Skilled Nursing Facilities
Substances
BNT162 Vaccine